Watch Replior CEO Christer Nilsson demo ScratchSense™ at Scope Summit – objective nocturnal scratch detection reducing variance in pruritus trials.
Replior explores how behavioural science transforms clinical trials — improving patient engagement, retention and data reliability through thoughtful, science-driven design.
Join Replior at OCT New England and Nordics to learn how behavioural science in ePRO improves retention, compliance and data integrity.
Replior and Pelotan team up to track UV exposure at the Tour de France, advancing athlete safety with real-time data and sun protection insights.
Replior’s new COO shares why he joined and how his global experience applies to a people-centered approach to clinical trials.
A behind-the-scenes look at how Replior rebuilt its EDC from the ground up—designed to adapt to real-world trial needs with greater flexibility, control, and speed.
After 20 years in clinical trials, Katri Langel reflects on what’s changed, what hasn’t, and why she joined Replior to help fix what’s broken.
What’s next for clinical trials? See our top takeaways from SCOPE 2025, including how sensor-driven data and patient engagement are changing the game.
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
Learn how EDC systems play a vital role in GDPR compliance for clinical trials, supporting data security, audit trails, and participant consent management.
